Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|March 19, 2024
Real-time measurements of ATP dynamics via ATeams in Plasmodium falciparum reveal drug-class-specific response patternsEric Springer, Kim C Heimsch, Stefan Rahlfs, et al.
Antimicrobial Agents and Chemotherapy|June 23, 2025
Arylmethylamino steroid compound 1o interferes with Plasmodium falciparum's hemoglobin metabolismEric Springer, Kim C Heimsch, Niklas Sidiropoulos, et al.
ACS Infectious Diseases|August 22, 2018
Stable Integration and Comparison of hGrx1-roGFP2 and sfroGFP2 Redox Probes in the Malaria Parasite Plasmodium falciparumAnna Katharina Schuh, Mahsa Rahbari, Kim C Heimsch, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 29, 2026
Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30Sarah M Metzger, Terry C Jones, Jenny I J Meier, et al.
Antioxidants & Redox Signaling|January 24, 2022
Structure and Function of Redox-Sensitive Superfolder Green Fluorescent Protein VariantKim C Heimsch, Christoph G W Gertzen, Anna Katharina Schuh, et al.
ACS Infectious Diseases|April 15, 2021
Plasmodium falciparum Ferredoxin-NADP+ Reductase-Catalyzed Redox Cycling of Plasmodione Generates Both Predicted Key Drug Metabolites: Implication for Antimalarial Drug DevelopmentBogdan Adam Cichocki, Maxime Donzel, Kim C Heimsch, et al.
Journal of Clinical Microbiology|March 14, 2025
External quality assessment of molecular detection and variant typing of SARS-CoV-2 in European expert laboratories in 2023Kim C Heimsch, Kamelia R Stanoeva, Ramona Mögling, et al.
ACS Infectious Diseases|January 5, 2022
Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood CellsGhizal Siddiqui, Carlo Giannangelo, Amanda De Paoli, et al.
Plos Pathogens|April 21, 2020
Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13Nina F Gnädig, Barbara H Stokes, Rachel L Edwards, et al.
Antimicrobial Agents and Chemotherapy|March 10, 2022
An Optimized Dihydrodibenzothiazepine Lead Compound (SBI-0797750) as a Potent and Selective Inhibitor of Plasmodium falciparum and P. vivax Glucose 6-Phosphate Dehydrogenase 6-PhosphogluconolactonaseIsabell Berneburg, Satyamaheshwar Peddibhotla, Kim C Heimsch, et al.
Pageof 1